Researchers harnessed artificial intelligence to identify hundreds of potential antibiotics from snake, scorpion, and spider venoms, offering a new avenue to tackle the rising global threat of antimicrobial resistance responsible for over one million deaths annually. This approach leverages venom-derived peptides’ unique bioactivity and AI's ability to predict therapeutic candidates, accelerating drug discovery against resistant pathogens.